3D Bioprinted Vascularized Lung Cancer Organoid Models with Underlying Disease Capable of More Precise Drug Evaluation

An advanced vascularized lung cancer (LC) model was proposed, which included patient-derived LC organoids, lung fibroblasts, and perfusable vessels using 3D bioprinting technology.